Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The American Journal of Physiology|December 1, 1989
Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeabilityJ A Royall, R L Berkow, J S Beckman, et al.
Medical and Pediatric Oncology|April 1, 1997
Retinal toxicity associated with cisplatin and etoposide in pediatric patientsL M Hilliard, R L Berkow, J Watterson, et al.
Cancer Research|June 15, 1993
In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activityR L Berkow, L Schlabach, R Dodson, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1984
Comparative responses of human polymorphonuclear leukocytes obtained by counterflow centrifugal elutriation and Ficoll-Hypaque density centrifugation. II. Membrane potential changes, membrane receptor analysis, membrane fluidity, and analysis of the effects of the preparative techniquesR L Berkow, S J Weisman, D Tzeng, et al.
Experimental Hematology|August 1, 1988
Cell culture studies and oncogene expression in juvenile chronic myelogenous leukemiaR J Gualtieri, R P Castleberry, J Gibbons, et al.
The American Journal of the Medical Sciences|December 1, 1994
A clinically applicable technique to study cytoskeletal dynamics in normal and abnormal polymorphonuclear leukocytes isolated from small volume blood samplesR G Watts, B M Gray, H S Patterson, et al.
The New England Journal of Medicine|July 5, 1979
Acute nonlymphocytic leukemia: expression in cells restricted to granulocytic and monocytic differentiationP J Fialkow, J W Singer, J W Adamson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A Phase I trial of bryostatin-1 in children with refractory solid tumors: a Pediatric Oncology Group studyS Weitman, A M Langevin, R L Berkow, et al.
Blood|March 1, 1985
Glycoprotein-180 deficiency: genetics and abnormal neutrophil activationS J Weisman, R L Berkow, G Plautz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group studyR P Castleberry, A B Cantor, A A Green, et al.
Pageof 4